<DOC>
	<DOCNO>NCT00259935</DOCNO>
	<brief_summary>The purpose study determine bioequivalence new oral capsule formulation currently use oral capsule formulation topotecan .</brief_summary>
	<brief_title>A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Subjects advance solid tumor . At least 4 week since last chemotherapy , radiotherapy , biologic therapy surgery . Subjects must free posttreatment side effect . Women pregnant lactating Subjects uncontrolled emesis , regardless etiology , active infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Any Solid Tumor</keyword>
</DOC>